Articles by Nathan Jessop - Pharmaceutical Executive

ADVERTISEMENT

Articles by Nathan Jessop

Pharma Job Cuts Cause Anxiety in Europe

With downsizing occurring more frequently than ever within the pharmaceutical industry, is Europe doing enough to curb further job losses that could threaten the recovery of its economy?
Jun 2, 2013

Is Europe doing enough to curb further job losses that could threaten the recovery of its economy?

European Biotech Struggles to Thrive

The outlook of the European biotech sector may not be as bleak as apparently believed despite the current economic climate.
May 6, 2013

While not as bleak as believed, the outlook of European biotech sector is struggling compared with its US counterpart.

European Pharma Depressed by German Pricing

Germany has shifted from a market where the pharmaceutical industry could enjoy considerable pricing freedom to a sensitive market influenced by cost-containment policies. However, pressure is being placed upon the country to change its pricing policy once again.
Aug 6, 2012

Germany has shifted from relative pricing freedom to a market that is sensitive and influenced by cost-containment policies. But pharma is pressuring the country to change its policy again.

European Pharma to Surge Ahead Of US?

The next two years may see a shake up in the world's current top pharmaceutical companies, with Pfizer likely to be the only US firm to remain in the top five by sales.
Jan 1, 2012

The next two years may see a shake up in the world's current top pharmaceutical companies, with Pfizer likely to be the only US firm to remain in the top five by sales.

ADVERTISEMENT

Click here